That is true, however the share price gap between A2m & BAL is quite large if you compare the 2 companies
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025